Research map: NLRC3 enhances antitumor immunity by specifically negatively regulating M-MDSCs in a STING-dependent manner
Back to the article
Papers in this map
STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling
· Hiroki Ishikawa · 2008 · 3600 citations · Cited by this paper
Macrophage CCRL2 promotes NLRP3 inflammasome activation to exacerbate atherosclerosis
· 2026 · Related
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
· Vincenzo Bronte · 2016 · 2816 citations · Cited by this paper
Mechanistic impasses: tofacitinib treatment ameliorates GM-CSF-driven macrophage inflammation
· 2026 · Related
Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth
· Mélanie Bruchard · 2012 · 794 citations · Cited by this paper
Melanosomes support immune evasion in melanoma
· 2026 · Related
γδT17 Cells Promote the Accumulation and Expansion of Myeloid-Derived Suppressor Cells in Human Colorectal Cancer
· Pin Wu · 2014 · 629 citations · Cited by this paper
T cell adaptation in chronic infections and tumors
· 2026 · Related
Host STING-dependent MDSC mobilization drives extrinsic radiation resistance
· Hua Laura Liang · 2017 · 498 citations · Cited by this paper
Cathepsin C orchestrates RSV-induced asthma exacerbation through the dual effect of monocyte-derived macrophages
· 2026 · Related
Myeloid-Derived Suppressor Cells
· Katherine H. Parker · 2015 · 485 citations · Cited by this paper
Lytic IFNγ is stored in cytotoxic granules and coreleased with granzyme B to mediate cytotoxic T lymphocyte killing
· 2026 · Related
The innate immune sensor NLRC3 attenuates Toll-like receptor signaling via modification of the signaling adaptor TRAF6 and transcription factor NF-κB
· Monika Schneider · 2012 · 352 citations · Cited by this paper
Defining the rules of engagement: B cells, antibodies and cancer control
· 2026 · Related
Trial watch: STING agonists in cancer therapy
· Julie Le Naour · 2020 · 293 citations · Cited by this paper
Vimentin trogocytosis as a novel mechanism of NK cell exhaustion by circulating tumor cells
· 2026 · Related
NLRC3, a Member of the NLR Family of Proteins, Is a Negative Regulator of Innate Immune Signaling Induced by the DNA Sensor STING
· Lu Zhang · 2014 · 275 citations · Cited by this paper
TWEAK receptor (Fn14) exacerbates TNF-α-induced inflammation in rheumatoid arthritis synovial fibroblasts and influences response to anti-TNF-α therapy
· 2026 · Related
NLRC3 is an inhibitory sensor of PI3K–mTOR pathways in cancer
· Rajendra Karki · 2016 · 224 citations · Cited by this paper
The Parkinson’s disease-linked G2019S mutation of LRRK2 increases NADPH oxidase-2 activity in neutrophils for superior control of bacterial infections
· 2026 · Related
ΔNp63-driven recruitment of myeloid-derived suppressor cells promotes metastasis in triple-negative breast cancer
· Sushil Kumar · 2018 · 203 citations · Cited by this paper
STING agonist therapy in combination with PD-1 immune checkpoint blockade enhances response to carboplatin chemotherapy in high-grade serous ovarian cancer
· Abdi Ghaffari · 2018 · 197 citations · Cited by this paper
Tumor-induced myeloid-derived suppressor cells promote tumor progression through oxidative metabolism in human colorectal cancer
· Li-Ying OuYang · 2015 · 191 citations · Cited by this paper
Myeloid-derived suppressor cells in cancer: therapeutic targets to overcome tumor immune evasion
· Junli Lu · 2024 · 165 citations · Cited by this paper
CATERPILLER 16.2 (CLR16.2), a Novel NBD/LRR Family Member That Negatively Regulates T Cell Function
· Brian J. Conti · 2005 · 162 citations · Cited by this paper
NLRC3 regulates cellular proliferation and apoptosis to attenuate the development of colorectal cancer
· Rajendra Karki · 2017 · 130 citations · Cited by this paper
A RIPK3-PGE2 Circuit Mediates Myeloid-Derived Suppressor Cell–Potentiated Colorectal Carcinogenesis
· Guifang Yan · 2018 · 126 citations · Cited by this paper
Targeting tumor monocyte-intrinsic PD-L1 by rewiring STING signaling and enhancing STING agonist therapy
· Huan Song · 2025 · 106 citations · Cited by this paper
The Innate Immune Sensor NLRC3 Acts as a Rheostat that Fine-Tunes T Cell Responses in Infection and Autoimmunity
· Toru Uchimura · 2018 · 82 citations · Cited by this paper
Viral DNA Binding to NLRC3, an Inhibitory Nucleic Acid Sensor, Unleashes STING, a Cyclic Dinucleotide Receptor that Activates Type I Interferon
· Xin Li · 2019 · 80 citations · Cited by this paper
The Development and Homing of Myeloid-Derived Suppressor Cells: From a Two-Stage Model to a Multistep Narrative
· Nathan Karin · 2020 · 73 citations · Cited by this paper
NLRC3 negatively regulates CD4+ T cells and impacts protective immunity during Mycobacterium tuberculosis infection
· Shengfeng Hu · 2018 · 67 citations · Cited by this paper
miR‐190b promotes tumor growth and metastasis via suppressing NLRC3 in bladder carcinoma
· Zhaohui Chen · 2020 · 48 citations · Cited by this paper
The Scaffolding Protein IQGAP1 Interacts with NLRC3 and Inhibits Type I IFN Production
· Aaron M. Tocker · 2017 · 42 citations · Cited by this paper
NLRC3 silencing accelerates the invasion of hepatocellular carcinoma cell via IL‐6/JAK2/STAT3 pathway activation
· Jianhua Kang · 2020 · 38 citations · Cited by this paper
Negative regulator NLRC3: Its potential role and regulatory mechanism in immune response and immune-related diseases
· Deyi Sun · 2022 · 38 citations · Cited by this paper
RNF213 promotes Treg cell differentiation by facilitating K63-linked ubiquitination and nuclear translocation of FOXO1
· Xiaofan Yang · 2024 · 34 citations · Cited by this paper
NLRC3 promotes host resistance against Pseudomonas aeruginosa-induced keratitis by promoting the degradation of IRAK1
· Litao Guo · 2017 · 21 citations · Cited by this paper
USP12 positively regulates M‐MDSC function to inhibit antitumour immunity through deubiquitinating and stabilizing p65
· Xiaoxia Zhan · 2022 · 21 citations · Cited by this paper
Source: OpenAlex (CC0)